ZAVZPRET is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine in adults Expands Pfizer’s migraine portfolio, which includes ...

from SAT 7:00 PM EST until SUN 1:00 PM EST, Meriwether County, Troup County, Haralson County, Morgan County, Walker County, Putnam County, Spalding County, Pike County, Jasper County, Hall County, ...

Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Pfizer is down 6 cents, or 0.2 percent, to $29.96, after the New York drug firm received approval to market Relpax, its acute treatment for migraine headaches, from the Food and Drug Administration.

A surgeon is seen here in an undated stock photo. automation A new study shows that FDA-approved oral migraine drug atogepant is effective for relieving difficult-to-treat "medication overuse ...

There’s fewer headaches around for companies that make and market migraine drugs, which are tracking substantial revenue growth. During Pfizer’s Q4 earnings call on Tuesday, chairman/ CEO Albert ...

Results provide evidence needed to challenge the step-through reimbursement requirements that have restricted Qulipta's ...

What Should You Know About Migraine Medications? There’s no cure for migraine, but treatment can help manage it. Preventive medications aim to reduce how often attacks happen, while rescue medications ...